Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CME in 'strongest position' for deals, CEO says, despite rising competition

Published 10/20/2023, 06:02 AM
Updated 10/20/2023, 11:52 AM
© Reuters. FILE PHOTO: Terry Duffy, Chairman and CEO of CME Group, speaks during the Piper Sandler Global Exchange and FinTech Conference in New York City, U.S., June 8, 2023. REUTERS/Brendan McDermid/File Photo

By Laura Matthews

NEW YORK (Reuters) - CME Group (NASDAQ:CME) is in strong position to make acquisitions, armed with low debt and robust earnings, Chief Executive Officer Terry Duffy told Reuters, even as the world's largest derivatives exchange operator faces rising competition.

Exchanges have been consolidating over the years and some have expanded beyond market-sensitive businesses like trading to pursue more predictable revenue.

CME, however, has registered three consecutive years of revenue growth as demand for hedging increased because of market volatility.

"I believe that we have put ourselves in the strongest position of anybody in our space globally as it relates to potential M&A," Duffy said in an interview, citing CME's strong earnings and AA- credit rating.

CME recently recorded its eighth-consecutive quarter of double-digit earnings growth.

CME's debt is less than one times its EBITDA, Duffy said, below the ratio of rivals Intercontinental Exchange (NYSE:ICE), Nasdaq and CBOE.

"Our capacity is much greater than anybody else's," Duffy said. "It doesn't mean we're going to do anything. If I think it benefits my users and my shareholders, we have the ability to do it."

CME had $2 billion in cash and $3.4 billion of debt as of June 30, recent earnings show. Its stock price is up 28% this year, compared to a 11% gain for the S&P 500.

Some analysts question whether CME can sustain growth internally when interest rates become more predictable, volatility decreases and more competition enters the exchange space.

Andrew Bond, senior fintech analyst at Rosenblatt Securities, has a sell rating on CME, saying "competitive threats are increasing to their business".

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In particular, BGC Group plans to launch Fenics Markets Xchange (FMX), a futures exchange for interest rate derivatives, pending regulatory approval.

A BGC representative was not immediately available for comment.

Bond said the most obvious candidate for acquisition is CBOE, a Chicago-based exchange operator whose shares rose nearly 3% in September on deal speculation after its CEO resigned.

Such a deal may be complex, however, involving spin-offs and antitrust concerns, Bond said.

Duffy declined to comment on potential targets. CBOE also declined to comment.

Investors would like CME to generate more stable sources of revenue for periods when markets are not volatile, Bond said.

CME generates more than 80% of its revenue from transactions, he said, and having other sources of revenue would help when trading volume growth could be difficult.

Duffy's last big acquisition was Nex Group in 2018 for $5.5 billion, following large deals to acquire Chicago Board of Trade and New York Mercantile Exchange a decade earlier.

But Duffy said he does not believe CME needs acquisitions to grow. CME could boost trading volumes as investors increasingly need to manage risk, he said.

Open interest, which tracks the number of open positions in a contract, has steadily increased in CME's rate products over the last three years.

The U.S. Federal Reserve's interest rate hikes led to record high average daily volumes at the exchange. Duffy, however, said a rate pause would still benefit CME because investors have views about where rates are heading, which will further boost trading volume.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.